Skip to main navigation Skip to search Skip to main content

July 2017 ENCALS statement on edaravone

  • Ammar Al-Chalabi
  • , Peter M. Andersen
  • , Siddharthan Chandran
  • , Adriano Chio
  • , Philippe Corcia
  • , Philippe Couratier
  • , Olof Danielsson
  • , Mamede de Carvalho
  • , Claude Desnuelle
  • , Torsten Grehl
  • , Julian Grosskreutz
  • , Trygve Holmøy
  • , Caroline Ingre
  • , Merete Karlsborg
  • , Grethe Kleveland
  • , Jan Christoph Koch
  • , Blaz Koritnik
  • , Magdalena KuzmaKozakiewicz
  • , Hannu Laaksovirta
  • , Albert C Ludolph
  • Christopher J Mcdermott, Thomas Meyer, Bernardo Mitre Ropero, Jesus Mora Pardina, Ingela Nygren, Susanne Petri, Mónica Povedano Panades, Francois Salachas, Pamela J Shaw, Vincenzo Silani, Gert Staaf, Kirsten Svenstrup, Kevin Talbot, Ole-Bjørn Tysnes, Philip Van Damme, Anneke J. van der Kooi, Markus Weber, Patrick Weydt, Joachim Wolf, Orla Hardiman, Leonard H van den Berg

Research output: Contribution to journalReview articlepeer-review

5 Downloads (Pure)
Original languageEnglish
Pages (from-to)471-474
Number of pages4
JournalAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Volume18
Issue number7-8
Early online date2017
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Journal Article
  • Antipyrine/analogs & derivatives
  • Humans
  • Amyotrophic Lateral Sclerosis/drug therapy
  • Decision Making/physiology
  • Treatment Outcome
  • Free Radical Scavengers/therapeutic use
  • Edaravone

Cite this